Guardant Health Inc (GH) support and resistance · rev $739.0M
Guardant Health Inc (GH) is a diagnostics & research company listed on US.
This page maps Guardant Health Inc (GH) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported GH revenue for 2024-12-31 was $739.0M. Net income was -$436.4M. Revenue was up 31.0% from 2023-12-31 to 2024-12-31. GH currently screens at market cap $6.32B.
GH currently screens at market cap $6.32B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new GH 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the GH quote page for the session range and the stock page for the full model.
Not investment advice.